相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Computational recognition of lncRNA signature of tumor-infiltrating B lymphocytes with potential implications in prognosis and immunotherapy of bladder cancer
Meng Zhou et al.
BRIEFINGS IN BIOINFORMATICS (2021)
Oxidative Phosphorylation Promotes Primary Melanoma Invasion
Amel Salhi et al.
AMERICAN JOURNAL OF PATHOLOGY (2020)
Immunoproteasome expression is associated with better prognosis and response to checkpoint therapies in melanoma
Shelly Kalaora et al.
NATURE COMMUNICATIONS (2020)
Prognostic value of macrophage polarization markers in epithelial neoplasms and melanoma. A systematic review and meta-analysis
Alvaro Lopez-Janeiro et al.
MODERN PATHOLOGY (2020)
Multimodel preclinical platform predicts clinical response of melanoma to immunotherapy
Eva Perez-Guijarro et al.
NATURE MEDICINE (2020)
Identification of hepatocellular carcinoma prognostic markers based on 10-immune gene signature
Kaifei Zhao et al.
BIOSCIENCE REPORTS (2020)
Establishment of a novel cell cycle-related prognostic signature predicting prognosis in patients with endometrial cancer
Jinhui Liu et al.
CANCER CELL INTERNATIONAL (2020)
Study of the Female Sex Survival Advantage in Melanoma-A Focus on X-Linked Epigenetic Regulators and Immune Responses in Two Cohorts
Abdullah Al Emran et al.
CANCERS (2020)
Observed Survival Interval: A Supplement to TCGA Pan-Cancer Clinical Data Resource
Jie Xiong et al.
CANCERS (2019)
Discovery of novel inhibitors of ribosome biogenesis by innovative high throughput screening strategies
Catherine E. Scull et al.
BIOCHEMICAL JOURNAL (2019)
A four-DNA methylation biomarker is a superior predictor of survival of patients with cutaneous melanoma
Wenna Guo et al.
ELIFE (2019)
An immune-related gene pairs signature predicts overall survival in serous ovarian carcinoma
Liuyan Zhang et al.
ONCOTARGETS AND THERAPY (2019)
Statistical predictions with glmnet
Solveig Engebretsen et al.
CLINICAL EPIGENETICS (2019)
Targeting the Ribosome Biogenesis Key Molecule Fibrillarin to Avoid Chemoresistance
Btissame El Hassouni et al.
CURRENT MEDICINAL CHEMISTRY (2019)
Cancer Statistics, 2018
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
An update on the Society for Immunotherapy of Cancer consensus statement on tumor immunotherapy for the treatment of cutaneous melanoma: version 2.0
Ryan J. Sullivan et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2018)
Distinct predictive biomarker candidates for response to anti-CTLA-4 and anti-PD-1 immunotherapy in melanoma patients
Priyanka B. Subrahmanyam et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2018)
Activation of central/effector memory T cells and T-helper 1 polarization in malignant melanoma patients treated with anti-programmed death-1 antibody
Kyoko Yamaguchi et al.
CANCER SCIENCE (2018)
Nivolumab plus ipilimumab or nivolumab alone versus ipilimumab alone in advanced melanoma (CheckMate 067): 4-year outcomes of a multicentre, randomised, phase 3 trial
Frank Stephen Hodi et al.
LANCET ONCOLOGY (2018)
Sex-specific effect of RNASEL rs486907 and miR-146a rs2910164 polymorphisms' interaction as a susceptibility factor for melanoma skin cancer
Antonella Sangalli et al.
MELANOMA RESEARCH (2017)
Intratumoral CD40 activation and checkpoint blockade induces T cell-mediated eradication of melanoma in the brain
Manisha Singh et al.
NATURE COMMUNICATIONS (2017)
Development and Validation of an Individualized Immune Prognostic Signature in Early-Stage Nonsquamous Non-Small Cell Lung Cancer
Bailiang Li et al.
JAMA ONCOLOGY (2017)
Targeting endothelin receptor signalling overcomes heterogeneity driven therapy failure
Michael P. Smith et al.
EMBO MOLECULAR MEDICINE (2017)
PRAME as an Independent Biomarker for Metastasis in Uveal Melanoma
Matthew G. Field et al.
CLINICAL CANCER RESEARCH (2016)
Melanoma therapy: Check the checkpoints
Masutaka Furue et al.
JOURNAL OF DERMATOLOGY (2016)
Phase I study of pegylated interferon-alpha-2b as an adjuvant therapy in Japanese patients with malignant melanoma
Naoya Yamazaki et al.
JOURNAL OF DERMATOLOGY (2016)
Regression in cutaneous melanoma: a comprehensive review from diagnosis to prognosis
S. Ribero et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2016)
Increased CCL17 serum levels are associated with improved survival in advanced melanoma
Benjamin Weide et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2015)
Pooled Analysis of Long-Term Survival Data From Phase II and Phase III Trials of Ipilimumab in Unresectable or Metastatic Melanoma
Dirk Schadendorf et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
Robust enumeration of cell subsets from tissue expression profiles
Aaron M. Newman et al.
NATURE METHODS (2015)
limma powers differential expression analyses for RNA-sequencing and microarray studies
Matthew E. Ritchie et al.
NUCLEIC ACIDS RESEARCH (2015)
The Genotype-Tissue Expression (GTEx) pilot analysis: Multitissue gene regulation in humans
Kristin G. Ardlie et al.
SCIENCE (2015)
Review The Cancer Genome Atlas (TCGA): an immeasurable source of knowledge
Katarzyna Tomczak et al.
Wspolczesna Onkologia-Contemporary Oncology (2015)
Molecular stratification of metastatic melanoma using gene expression profiling : Prediction of survival outcome and benefit from molecular targeted therapy
Helena Cirenajwis et al.
ONCOTARGET (2015)
AKT1 Activation Promotes Development of Melanoma Metastases
Joseph H. Cho et al.
CELL REPORTS (2015)
Role of Chitinase 3-like-1 and Semaphorin 7a in Pulmonary Melanoma Metastasis
Bing Ma et al.
CANCER RESEARCH (2015)
Risk factors related to late metastases in 1,372 melanoma patients disease free more than 10 years
Simona Osella-Abate et al.
INTERNATIONAL JOURNAL OF CANCER (2015)
Knockdown of lecithin retinol acyltransferase increases all-trans retinoic acid levels and restores retinoid sensitivity in malignant melanoma cells
Philipp M. Amann et al.
EXPERIMENTAL DERMATOLOGY (2014)
ImmPort: disseminating data to the public for the future of immunology
Sanchita Bhattacharya et al.
IMMUNOLOGIC RESEARCH (2014)
No longer an untreatable disease: How targeted and immunotherapies have changed the management of melanoma patients
Maria Romina Girotti et al.
MOLECULAR ONCOLOGY (2014)
Lecithin retinol acyltransferase as a potential prognostic marker for malignant melanoma
Jessica C. Hassel et al.
EXPERIMENTAL DERMATOLOGY (2013)
The Society for Immunotherapy of Cancer consensus statement on tumour immunotherapy for the treatment of cutaneous melanoma
Howard L. Kaufman et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2013)
Inferring tumour purity and stromal and immune cell admixture from expression data
Kosuke Yoshihara et al.
NATURE COMMUNICATIONS (2013)
Vitamin A metabolism in benign and malignant melanocytic skin cells: Importance of lecithin/retinol acyltransferase and RPE65
Philipp M. Amann et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2012)
Importance of glycolysis and oxidative phosphorylation in advanced melanoma
Jonhan Ho et al.
MOLECULAR CANCER (2012)
Evaluating the added predictive ability of a new marker: From area under the ROC curve to reclassification and beyond
Michael J. Pencina et al.
STATISTICS IN MEDICINE (2008)
The function of programmed cell death 1 and its ligands in regulating autoimmunity and infection
Arlene H. Sharpe et al.
NATURE IMMUNOLOGY (2007)
Mechanisms of disease - Melanoma
Arlo J. Miller et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Principles and use of anti-CTLA4 antibody in human cancer immunotherapy
KS Peggs et al.
CURRENT OPINION IN IMMUNOLOGY (2006)
Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles
A Subramanian et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Gene Expression Omnibus: NCBI gene expression and hybridization array data repository
R Edgar et al.
NUCLEIC ACIDS RESEARCH (2002)
High- and low-dose interferon alfa-2b in high-risk melanoma: First analysis of Intergroup Trial E1690/S9111/C9190
JM Kirkwood et al.
JOURNAL OF CLINICAL ONCOLOGY (2000)
分享论文
